
---
title: Antiemetics (INICET Cheat Sheet)
markmap:
  colorFreezeLevel: 6
---

## Antiemetics

-   **Mechanisms & Classes**
    -   **5-HT₃ Antagonists (Serotonin)**
        -   Drugs: Ondansetron, Granisetron, Palonosetron (long T½, less QT)
        -   MOA: Block 5-HT₃ (CTZ, GIT)
        -   Uses: CINV (Acute, high risk), PONV
        -   SE: Headache, Constipation, QT Prolongation (Ondansetron > Granisetron)
    -   **D₂ Antagonists (Dopamine)**
        -   Drugs: Metoclopramide, Domperidone, Prochlorperazine, Promethazine
        -   MOA: Block D₂ (CTZ)
        -   Uses: CINV, PONV, Gastroparesis (Metoclopramide, Domperidone), Vertigo (Prochlorperazine)
        -   SE: EPS (Metoclopramide, Prochlorperazine), Hyperprolactinemia (Metoclopramide, Domperidone), Sedation, QT Prolongation (Droperidol, IV Domperidone)
        -   Domperidone: Less BBB entry -> less EPS, more hyperprolactinemia
    -   **NK₁ Receptor Antagonists (Substance P)**
        -   Drugs: Aprepitant, Fosaprepitant (prodrug), Netupitant/Palonosetron
        -   MOA: Block NK₁
        -   Uses: CINV (Delayed, high risk)
        -   SE: Fatigue, Hiccups, CYP3A4 interactions
    -   **Antihistamines (H₁ Blockers)**
        -   Drugs: Promethazine, Cyclizine, Meclizine, Dimenhydrinate
        -   MOA: Block H₁ (Vestibular nuclei, CTZ)
        -   Uses: Motion Sickness, Vertigo
        -   SE: Sedation, Anticholinergic effects
    -   **Anticholinergics (Muscarinic)**
        -   Drug: Hyoscine (Scopolamine)
        -   MOA: Block M₁ (Vestibular nuclei)
        -   Uses: Motion Sickness (Patch)
        -   SE: Anticholinergic effects (Dry mouth, blurred vision)
    -   **Corticosteroids**
        -   Drug: Dexamethasone
        -   MOA: Adjuvant (synergy), reduces inflammation
        -   Uses: CINV (synergy with 5-HT₃, NK₁), PONV
        -   SE: Insomnia, Dyspepsia
    -   **Cannabinoids**
        -   Drugs: Dronabinol, Nabilone
        -   MOA: CB₁ receptor
        -   Uses: Refractory CINV
        -   SE: Psychoactive effects, Sedation

-   **High Yield Scenarios**
    -   **CINV**
        -   Acute (<24h): 5-HT₃ + Dexamethasone +/- NK₁ (High Risk)
        -   Delayed (>24h): NK₁ + Dexamethasone +/- 5-HT₃
        -   High Risk CINV: NK₁ + 5-HT₃ + Dexamethasone (Triple Therapy)
    -   **PONV**
        -   Prophylaxis: Multimodal (5-HT₃, Dexamethasone, Droperidol, NK₁)
    -   **Motion Sickness:** Antihistamines, Hyoscine
    -   **Gastroparesis:** Metoclopramide, Domperidone
    -   **Vertigo:** Antihistamines, Prochlorperazine

-   **INICET Buzzwords**
    -   EPS (Metoclopramide, Prochlorperazine)
    -   QT Prolongation (Ondansetron, Droperidol, IV Domperidone)
    -   CINV (Acute/Delayed)
    -   PONV
    -   Motion Sickness
    -   Gastroparesis
    -   Hyperprolactinemia (Metoclopramide, Domperidone)
    -   Aprepitant (Delayed CINV, CYP3A4)
    -   Palonosetron (Longest T½ 5-HT₃)
    -   Dexamethasone (Adjuvant in CINV/PONV)
    -   Refractory CINV (Cannabinoids)
    -   Domperidone (less EPS than Metoclopramide)
